Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2016 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent Biosolutions to Participate in the Bank of America Merrill Lynch Healthcare Conference in May 2016

GAITHERSBURG, Md., April 26, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the Bank of...
April 21, 2016 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call on May 5, 2016

GAITHERSBURG, Md., April 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 5, 2016 at 5:00 pm (Eastern Time) to discuss the...
April 20, 2016 09:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Presents Preclinical Data on ES425 a Bispecific Immunotherapeutic Protein for Triple-Negative Breast Cancer

GAITHERSBURG, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it presented preclinical data on its bispecific ADAPTIRTM (modular protein...
April 18, 2016 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Submits sBLA for FDA Approval of Large-Scale Manufacturing of BioThrax in Building 55

GAITHERSBURG, Md., April 18, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S....
April 15, 2016 17:30 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Filing of Form 10 Registration Statement for Its Planned Spin-Off of Its Biosciences Business Aptevo Therapeutics

GAITHERSBURG, Md., April 15, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the initial filing of a Form 10 Registration Statement with the U.S. Securities and...
March 30, 2016 07:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Participate in Needham & Company’s 15th Annual Healthcare Conference in April 2016

GAITHERSBURG, Md., March 30, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in Needham...
February 25, 2016 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2015 Financial Results and Reaffirms 2016 Outlook

GAITHERSBURG, Md., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and twelve months ended December 31, 2015. 2015 FINANCIAL...
February 17, 2016 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions’ Emergard Auto-Injector Platform for Nerve Agent Antidote Delivery Selected by U.S. Department of Defense and Battelle for Testing and Development

GAITHERSBURG, Md., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Emergard™, the company’s ruggedized, military-grade auto-injector platform, has been...
February 11, 2016 07:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Fourth Quarter and Full Year 2015 Financial Results and Conduct a Conference Call on February 25, 2016

GAITHERSBURG, Md., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 25, 2016 at 5:00 pm (Eastern Time) to discuss the...
January 21, 2016 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Executive Management Team of New Spin-Off Company Aptevo Therapeutics

GAITHERSBURG, Md., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the anticipated executive management team of Aptevo Therapeutics Inc., Emergent’s planned...